On the way to a more effective treatment for colorectal...
The drug candidate arfolitixorin is designed to improve the efficacy of existing chemotherapy rather...
Published: 27 October, 2026
Here you will find news, articles and features about Isofol and our business. Browse current and past publications.
Sorry, nothing matches this category.
The drug candidate arfolitixorin is designed to improve the efficacy of existing chemotherapy rather...
Published: 27 October, 2026
Isofol's CEO Petter Segelman Lindqvist talks about the company's focus and the subscription options of...
Published: 27 October, 2026
“The second quarter of 2026 was characterised by a continued strong focus on driving the clinical development...
Published: 19 October, 2026